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The trans-Golgi SNARE syntaxin 10 is
required for optimal development of
Chlamydia trachomatis
Andrea L. Lucas, Scot P. Ouellette, Emily J. Kabeiseman, Kyle H. Cichos and
Elizabeth A. Rucks*
Division of Basic Biomedical Sciences, Sanford School of Medicine, University of South Dakota, Vermillion, SD, USA
Chlamydia trachomatis, an obligate intracellular pathogen, grows inside of a vacuole,
termed the inclusion. Within the inclusion, the organisms differentiate from the infectious
elementary body (EB) into the reticulate body (RB). The RB communicates with the
host cell through the inclusion membrane to obtain the nutrients necessary to divide,
thus expanding the chlamydial population. At late time points within the developmental
cycle, the RBs respond to unknown molecular signals to redifferentiate into infectious
EBs to perpetuate the infection cycle. One strategy for Chlamydia to obtain necessary
nutrients and metabolites from the host is to intercept host vesicular trafficking pathways.
In this study we demonstrate that a trans-Golgi soluble N-ethylmaleimide–sensitive
factor attachment protein (SNARE), syntaxin 10, and/or syntaxin 10-associated Golgi
elements colocalize with the chlamydial inclusion. We hypothesized that Chlamydia
utilizes the molecular machinery of syntaxin 10 at the inclusion membrane to intercept
specific vesicular trafficking pathways in order to create and maintain an optimal
intra-inclusion environment. To test this hypothesis, we used siRNA knockdown of
syntaxin 10 to examine the impact of the loss of syntaxin 10 on chlamydial growth and
development. Our results demonstrate that loss of syntaxin 10 leads to defects in normal
chlamydial maturation including: variable inclusion size with fewer chlamydial organisms
per inclusion, fewer infectious progeny, and delayed or halted RB-EB differentiation.
These defects in chlamydial development correlate with an overabundance of NBD-lipid
retained by inclusions cultured in syntaxin 10 knockdown cells. Overall, loss of syntaxin
10 at the inclusion membrane negatively affects Chlamydia. Understanding host
machinery involved in maintaining an optimal inclusion environment to support chlamydial
growth and development is critical toward understanding the molecular signals involved
in successful progression through the chlamydial developmental cycle.
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Introduction
Chlamydia are obligate intracellular pathogens and multiply within mucosal epithelial cells. The
organisms grow inside host cells within an enclosedmembrane bound vacuole termed an inclusion.
C. trachomatis infections negatively impact human health worldwide and are associated with both
genital (serovars D–K and LGV L1-3) and ocular infections (serovars A–C); (Schachter, 1999; Datta
et al., 2007; Centers for Disease Control and Prevention, 2012). Notably, C. trachomatis is the most
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commonly reported bacterial sexually transmitted disease in
the United States. Chlamydial sexually transmitted infections
are predominantly asymptomatic, which perpetuates the spread
of disease to unsuspecting partners. Prolonged chlamydial
infection, often associated with asymptomatic disease, can result
in infertility problems for women and an increased risk of
acquiring HPV or HIV (Centers for Disease Control and
Prevention, 2012).
All Chlamydia spp. have a biphasic developmental cycle
in which the organisms alternate between two different
developmental forms (Abdelrahman and Belland, 2005).
The infectious elementary body (EB) rapidly differentiates
into a replicative, non-infectious reticulate body (RB). The
developmental cycle is completed when RBs redifferentiate into
infectious EBs and exit the host cell (Ward, 1988; Abdelrahman
and Belland, 2005). Initially the inclusionmembrane is composed
of primarily host cell plasma membrane but becomes studded
with chlamydial proteins secreted by a type III secretion system
(Fields et al., 2003). This allows the inclusion to disassociate
from the endocytic pathway to avoid fusion with the lysosome
(Heinzen et al., 1996; Taraska et al., 1996; Van Ooij et al., 1997;
Fields et al., 2003; Scidmore et al., 2003). The entirety of the
development cycle occurs within the confines of a pathogen-
specified parasitic organelle termed the chlamydial inclusion
(Moore and Ouellette, 2014).
Chlamydia species have evolved closely with their host
resulting in significant genome reduction. Chlamydia synthesize
some of their own nutrients, amino acids, and nucleic acids,
but, where chlamydial biosynthetic pathways have been lost, the
organisms acquire essential metabolites from the host (Wylie
et al., 1997; Stephens et al., 1998; McClarty, 2004; Elwell and
Engel, 2012). For example, RBs lack the ability to actively
synthesize some of the lipids which are found in their cell
walls such as glycerophospholipids and phosphatidylcholine,
suggesting they acquire these lipids from the host (Wylie
et al., 1997). Despite the great metabolic needs of chlamydial
organisms, the host cell is not overtly stressed by a chlamydial
infection, suggesting that Chlamydia work in collaboration with
the host cell in order to obtain the necessary and required
nutrients which support chlamydial growth and development
(Moore and Ouellette, 2014). To this end, chlamydial organisms
have developed the ability to redirect necessary metabolites to the
inclusion (Hackstadt et al., 1995; Heinzen et al., 1996). Golgi-
derived lipid trafficking to the inclusion is, in part, vesicular
in nature (Hackstadt et al., 1996); however, non-vesicular
mechanisms have also been demonstrated (Cocchiaro et al., 2008;
Derré et al., 2011; Elwell et al., 2011). A polarized cell model of
chlamydial infection determined that Chlamydia preferentially
intercept Golgi-derived vesicles in route to the basolateral plasma
membrane (Moore et al., 2008). In order to define eukaryotic
and chlamydial inclusion membrane fusion events, we examined
host proteins that govern membrane fusion along basolateral
trafficking pathways. SNARE proteins syntaxin 6 and VAMP4,
but not syntaxins 4, 5, or 16, localize to the chlamydial inclusion
(Moore et al., 2011; Kabeiseman et al., 2013). These observations
emphasize the specific interaction that the inclusion membrane
has with host SNARE proteins.
We hypothesize that Chlamydia utilizes components of
the eukaryotic molecular machinery to facilitate membrane
fusion events at the chlamydial inclusion to optimize nutrient
acquisition. In testing this hypothesis, we demonstrate that
syntaxin 10 localizes to the chlamydial inclusion. Further, loss
of syntaxin 10 due to siRNA knockdown results in detrimental
delays to chlamydial growth and development. These data
suggest that syntaxin 10 contributes to a cellular process required
to support an optimum growing environment for Chlamydia.
Materials and Methods
Cell Culture and Chlamydial Organisms
HeLa 229 cells (ATCC-CCL-2.1; Manassas, VA) were cultured
as previously described (Kabeiseman et al., 2013). HEp2 cells
(Harlan Caldwell, Rocky Mountain Laboratories, Hamilton,
MT) were maintained in Iscove’s Modified Dulbecco’s medium
(Gibco/Life Technologies, Carlsbad, CA) supplemented with
10% fetal bovine serum (GE Healthcare Hyclone, Logan, UT).
Chlamydia trachomatis L2 were propagated in HeLa cells or
HEp2 cells and infectious elementary bodies (EBs) were isolated,
enumerated, and stocks were stored at -80◦C as previously
described (Furness et al., 1960; Caldwell et al., 1981; Scidmore,
2005).
3XFLAG-syntaxin 10 Transfections and Bacterial
Infections
Syntaxin 10 (GenBank accession number CR457110) cDNA
(Eurofins MWG Operon; Huntsville, Alabama) served as a
template to clone syntaxin 10. The forward primer (5′-
ggggggaattcaatgtctctcgaagacccctttt-3′) contained a 5′ EcoRI
site (all caps, underlined), and the reverse primer (5′-
gggggGGATCCtcagagagagaatagtaagatgagaa-3′) contained a 3′
BamHI site (all caps, underlined), which were used to subclone
syntaxin 10 into the multiple cloning site of the p3XFLAG-
CMV 7.1 expression vector (Sigma; St. Louis, MO). Sequence
was verified by Eurofins MWG Operon, Huntsville, AL. 100 ng
of plasmid DNA was transfected with Lipofectamine 2000
Transfection (Life Technologies, Carlsbad, CA) and Opti-MEM
(Life Technologies), according to the manufacturer’s protocol.
Cells were then infected with Chlamydia as described previously
(Scidmore, 2005).
Immunofluorescence Microscopy
HeLa cells were seeded onto 12mm glass coverslips 24 h before
transfection of the appropriate construct, followed by infection
with C. trachomatis serovar L2. 16–18 h post-infection, cells
were fixed in 4% paraformaldehyde (Acros Organics/Thermo
Scientific; Logan, UT) and permeabilized with 0.5% TritonX-
100 for 5min. Coverslips were incubated with primary antibody:
mouse anti-FLAG M2 (Sigma Aldrich), rabbit anti-IncA (Ted
Hackstadt, Rocky Mountain Laboratories, Hamilton, MT), rabbit
anti-IncG (Ted Hackstadt), or rabbit anti-giantin (Covance;
Emeryville, CA), followed by incubation with the appropriate
secondary antibody conjugated to DyLight fluors (Jackson
ImmunoResearch Laboratories; West Grove, PA). Coverslips
were mounted on glass microscope slides using Prolong Gold
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mounting reagent (Life Technologies). Slides were visualized
with an 60X objective and 2x zoom using an Olympus Fluoview
1000 Laser Scanning Confocal Microscope.
siRNA Transfection
Silencer select siRNA (Life Technologies) against syntaxin 10
(Stx10); (s16535) and non-targeting control (NT); (4390843)
were used at a final concentration of 10 nM. All siRNA
clones were validated by Life Technologies according to
their procedures. Three different siRNA clones against Stx10
were used (ID number-137195, ID number-137196, and ID
number-137197) to quantify chlamydial infectious progeny at
44 h of infection. Based on similar results between all Stx10
siRNAs (data not shown), Stx10 ID number-137197 was used
for all subsequent siRNA experiments. siRNA was delivered
to HeLa cells via reverse transfection using Lipofectamine
RNAiMAX siRNA Transfection Reagent and Opti-MEM media
(Life Technologies), following the manufacturer’s protocol. For
all siRNA knockdown experiments, monolayers were infected
with C. trachomatis serovar L2 48 h after siRNA transfection.
Efficiency of knockdown was confirmed by Western blot and
densitometry analysis using Odyssey Infrared Imaging System
using Image Studio imaging software (LI-COR, Lincoln, NE).
Only samples achieving 70% or greater knockdown efficiency
were used in subsequent studies.
Quantification of Inclusion Formation and
Chlamydial Infectious Progeny
Through the course of our studies, we recognized that syntaxin
10 knockdown cells do not divide at the same rate as cells
transfected with non-targeting siRNA. Therefore, on the day of
infection, cells were enumerated in order to infect all monolayers
at a multiplicity of infection (moi) of 0.5 bacteria per eukaryotic
cell. To assess inclusion formation, monolayers were fixed
and processed for immunofluorescence to detect chlamydial
inclusions and host nuclei. 7–10 fields of view from 3 separate
coverslips were enumerated. Infectious progeny produced at
24, 44, and 67 h post-infected were harvested and replated
onto HEp2 cells, essentially as previously described (Kabeiseman
et al., 2013). Serial dilutions of infectious progeny were plated
in triplicate and 10 fields of view from each coverslip were
enumerated. Because there were greater numbers of cells in the
wells transfected with non-targeting siRNA, a greater number
of bacteria were used to reach an moi of 0.5. Therefore, to
correct for this disparity, the inclusion forming units (IFU)
obtained from wells transfected with non-targeting siRNA were
divided by the increased number of bacteria compared to the
inoculum of syntaxin 10 siRNA-treated cells. Data shown are
from one experiment, but are consistent with all 3 independent
experiments. These values were calculated and graphed using
GraphPad Prism 6 Software (GraphPad Software, La Jolla, CA),
as described below. As the monolayer in the NT siRNA treated
cells was destroyed at 67 h post-infection, the knockdown of
syntaxin 10 at the 67 h time point was determined by comparing
the ratio of syntaxin 10 to GAPDH to the 44 h time point of the
NT siRNA treated cells.
Chlamydial Protein Expression by SDS-PAGE and
Western Blot Analysis
siRNA transfected cells were infected with Chlamydia
as described above. Samples were separated on an SDS-
12%PAGE and transferred using an iBlot transfer apparatus
(Life Technologies). Primary antibodies used in this study
include: rabbit anti-syntaxin 10 (Abgent; SanDiego, CA), mouse
anti-GAPDH (EMD Millipore; Darmstadt, Germany), rabbit
anti-Hc1 (Ted Hackstadt), rabbit anti-OmcB (Thomas Hatch,
University of Tennessee Health Science Center, Memphis,
TN), and mouse anti-HSP60 (Rick Morrison, Department of
Microbiology and Immunology, University of Arkansas for
Medical Sciences, Little Rock, AR). The primary antibodies
were detected using appropriate anti-mouse or anti-rabbit IgG
secondary antibodies conjugated with IRDye 700 or IRDye
800 dyes (LI-COR). The blots were scanned and analyzed by
densitometry with an Odyssey Infrared Imaging System using
Image Studio imaging software (LI-COR). To quantitate OmcB
and Hc1 protein levels, densitometry values were normalized to
cHSP60, which was first normalized to host GAPDH. Data are
representative of two independent experiments and results are
expressed as mean and standard error of the mean, calculated by
GraphPad Prism 6 software.
Transmission Electron Microscopy (TEM)
Syntaxin 10 siRNA or non-targeting control siRNA transfected
monolayers were infected with C. trachomatis serovar L2 for
36 h. Infected monolayers were collected and fixed in 2% EM-
grade paraformaldehyde plus 2.5% EM-grade glutaraldehyde
(Polysciences Inc., Warrington, PA) in 100mM sodium
phosphate buffer (Sigma Aldrich). Cells were processed for TEM
as described previously (Beatty, 2006). TEM images were taken
for two independent experiments. TEM images were used to
quantify total numbers of organisms per inclusion, percentage of
developmental forms in each inclusion and inclusion diameter.
The diameter measurement was taken at the widest part of each
inclusion. The results are displayed as µm units, based on the
scale set from the electron microscope. All means and standard
error of the means were calculated using GraphPad Prism 6
software.
Live Cell Imaging
At the indicated time points after infection with C.
trachomatis serovar L2, cells were labeled with 5µM 6-((N-(7-
nitrobenz-2-oxa-1, 3-diazol-4-yl)amino)hexanoyl)sphingosine
(C6-NBD-ceramide); (Life Technologies) as described previously
(Hackstadt et al., 1995; Moore, 2012; Kabeiseman et al., 2013).
Phase contrast and fluorescent live cell images were acquired at
the indicated time points post back-exchange using the 40X phase
objective with the Axiovert 200M Imager with the AxioCam
HRm camera (Carl Zeiss Microscopy, LLC; Thornwood, NY).
To quantify the relative brightness of the inclusions (per area of
the individual inclusions) cultured in non-targeting control (NT)
or syntaxin 10 (stx10) siRNA-treated cells, cells were infected
with C. trachomatis for 30 h, labeled with C6-NBD-ceramide
and back-exchanged for 1.5 h. Coverslips were mounted onto
glass slides and imaged at 40ms (NT) or 20ms (Stx10) exposure
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times (to prevent saturation) with an Olympus BX 60 fluorescent
scope (60X magnification) and images taken with a Nikon
DS-Qi1Mc camera. 20 images were taken from two independent
experiments, each performed in duplicate (40 images were
processed for each independent experiment). The fluorescent
intensity (integrated density) and area of the inclusion were
determined with ImageJ v1.48 (National Institutes of Health,
Bethesda, MD). Measuring the integrated density and area
of the “brightest” non-inclusion-associated background and
subtracting that amount from inclusion measurements corrected
all measurements for background fluorescence. Mean and
standard error of the mean were calculated and graphed using
GraphPad Prism 6 software.
Statistics and Image Production
All quantification and statistical analysis of data were performed
with GraphPad Prism 6 Software. Statistical analyses used include
an ordinary one-way analysis of variance (ANOVA) with a
Tukey’s multiple comparison post-hoc test, or Student’s t-test,
as appropriate. The use of specific statistical tests is indicated
in the associated figure legends. All figures were constructed
using Adobe Photoshop CS5 (Adobe Systems Incorporated, San
Jose, CA). Modifications to images include adjustment to color
balance in fluorescent images, applied equally to all images in a
single figure, with the exception of live cell images appearing in
Figure 5A to which no adjustments were made. Brightness and
contrast were adjusted in Western blot images.
Results
Colocalization of Syntaxin 10 with the Chlamydial
Inclusion
Previous studies demonstrated that trans-Golgi SNARE proteins
syntaxin 6 and VAMP4 localize to the chlamydial inclusion
(Moore et al., 2011; Kabeiseman et al., 2013). We hypothesize
that Chlamydia recruit specific SNARE proteins to help the
chlamydial inclusion maintain an optimal growing environment
for the pathogens. Missing from these previous analyses was
an understanding of whether syntaxin 10, another trans-
Golgi SNARE, localized to the chlamydial inclusion. We
initially tried to visualize endogenous syntaxin 10 by indirect
immunofluorescence, but commercially available antibodies
were not suitable for this application. Therefore, for these
studies, we transfected HeLa cells with a 3XFLAG-syntaxin 10
construct, which localized in vesicular-like structures throughout
the cell and within the Golgi apparatus (Figure 1A). By
confocal microscopy, exogenously expressed 3XFLAG-syntaxin
10 colocalized with two inclusion membrane markers: IncA
and IncG (Figures 1B,C). What is apparent in these images
is the vesicular nature of 3XFLAG-syntaxin 10 structures at
the inclusion. 3XFLAG-syntaxin 10 does not form a distinct
rim, as other eukaryotic proteins that localize to the chlamydial
inclusion. Rather, it resembles a collection of vesicles, presumably
Golgi-elements, since syntaxin 10 is strongly associated with the
trans-Golgi network. Due to the localization pattern of syntaxin
10, the timing of the localization of 3XFLAG-syntaxin 10 at
early time points post-infection is difficult to determine, but it
FIGURE 1 | Syntaxin 10 localization to the chlamydial inclusion. (A)
HeLa cells were transfected with 3XFLAG-syntaxin 10 (3XF-stx10) for 24 h
prior to fixation and processing for imaging. The Golgi (outlined in white) was
detected with a rabbit anti-giantin antibody; 3XF-Stx10 was detected using a
mouse anti-FLAG M2 antibody. (B,C) HeLa or HEp2 cells transfected with
3XF-stx10 were infected for 16–18 h with C. trachomatis serovar L2, prior to
fixation and processing for imaging. The inclusion membrane was detected
using either a rabbit anti- IncA (B) (Additional images provided in Supplemental
Figure 1) or IncG (C) antibody; 3XF-Stx10 was detected as above. To
distinguish 3XF-Stx10 from surrounding cell structures, some samples were
treated with brefeldin A (BFA) to collapse the surrounding Golgi. To examine if
chlamydial protein synthesis was required for 3XF-Stx10 localization, infected
monolayers were treated with 200µg/ml chloramphenicol (Chlor) for an
additional 24 h prior to fixation. In chloramphenicol treated cells, white
asterisks indicate inclusions. All images were acquired using an Olympus
Fluoview 1000 Laser Scanning Confocal Microscope with a 60X objective and
2x zoon. These results are representative of at least 3 independent
experiments. White bars = 10µm.
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likely occurs at some point between 8 and 14 h post-infection
and remains associated with the inclusion beyond 36 h post-
infection (Supplemental Figure 1). To distinguish 3XFLAG-
syntaxin 10 that localized to the inclusion from surrounding
cellular structures, cells were treated with 1µg/ml of brefeldin
A (BFA), which collapses the Golgi into the ER (Lippincott-
Schwartz et al., 1989), for 2 h prior to fixation. BFA treatment did
not eliminate the localization of 3XFLAG-syntaxin 10 with the
inclusion, indicating that the localization of 3XFLAG-syntaxin
10 is not happenstance due to the inclusion’s proximity with
the Golgi (Figure 1C). As indicated in Figure 1C, association
of these syntaxin 10 positive structures with the inclusion
likely stabilizes the structures from the effects of BFA. Notably,
inhibition of chlamydial protein synthesis at 18 h post-infection
by chloramphenicol did not abolish the localization of 3XFLAG-
syntaxin 10 to the chlamydial inclusion (Figure 1C, last row).
These data indicate that once syntaxin 10 or syntaxin 10-positive
structures are trafficked to the inclusion that the interaction is
likely with a stable (i.e., low turnover) chlamydial protein. We
were unable to determine if treatment of infected monolayers
with chloramphenicol during early time points of infection
inhibits localization of syntaxin 10 or syntaxin 10 positive
structures with the inclusion (Supplemental Figure 1A).
The Effect of Syntaxin 10 Knockdown on
Inclusion and Chlamydial Growth and
Development
The pattern of localization of syntaxin 10 to the chlamydial
inclusion membrane suggested that this protein has a function
for Chlamydia. To understand the relationship of syntaxin 10
with the Golgi, we initially used siRNA to knockdown syntaxin 10
and examined Golgi morphology (using Golgi protein, Giantin)
around the chlamydial inclusion (Supplemental Figure 2). In
control cells (cells transfected with non-targeting siRNA), the
Golgi is condensed and encircles the chlamydial inclusion,
as previously characterized (Heuer et al., 2009). In syntaxin
10 knockdown cells, the Golgi retains a discernable vesicular
structure, but the tight association with the inclusion is partially
lost. This suggests a potential role for syntaxin 10 and/or
associated interacting protiens (i.e., Incs) in anchoring the Golgi
to the inclusion. In the context of our working hypothesis, these
data support a role for syntaxin 10 in contributing to an optimal
environment for chlamydial development. We cannot readily
distinguish between vesicular trafficking defects or “relaxed”
Golgi effects on chlamydial development. However, previous
studies have demonstrated that loss of Golgi morphology does
not negatively impact chlamydial development (Hackstadt et al.,
1996). As a first step in understanding the function of syntaxin
10 in chlamydial growth and development, we began by assessing
the ability of organisms to produce infectious progeny 24,
44, and 67 h post-infection (Figure 2A). In a typical serovar
L2 developmental cycle (organisms grown in HeLa or HEp2
cells), rapid division of RBs occurs between 8 and 16 h post-
infection, with RB to EB differentiation occurring 24 to 36 h
post-infection. Maximal RB to EB transition occurs between 42
and 48 h post-infection, with subsequent monolayer destruction
due to maximal EB release occurring at or after 50+ h of
FIGURE 2 | Effect of siRNA knockdown of syntaxin 10 on inclusion
development and chlamydial infectious progeny. (A) Syntaxin 10 (Stx10)
or NT (non-targeting, control) siRNA-treated HeLa cells were infected at an
MOI of 0.5 with C. trachomatis serovar L2 for 24, 44, or 67 h. Monolayers
were lysed in dH2O, then serial dilutions were replated onto a fresh monolayer
of cells. These cells were fixed and processed to enumerate inclusions.
Inclusions were counted using a 20X objective and values are expressed as
mean and standard error of the mean and then analyzed with an ordinary
One-Way ANOVA with a Tukey’s multiple comparison test in GraphPad Prism
6 software. Data are representative of 3 independent experiments. (B)
Corresponding Western blot of cell lysates harvested at the time points
described above to test for efficient knockdown of syntaxin 10 (stx10)
compared to loading control GAPDH.
infection (Ward, 1988; Dessus-Babus et al., 2008). Consistent
with the progression of the normal chlamydial developmental
cycle, there are low numbers of infectious progeny produced in
both siRNA treatment groups (NT: 3.54 × 104 ± 3.97 × 103;
Stx10: 2.41 × 104 ± 2.24 × 103) after 24 h of infection (mid-
developmental cycle), indicating that chlamydial development
is not altered due to depletion of syntaxin 10 at this time
point post-infection. However, after 44 h of infection (late
developmental cycle), there is a statistically and biologically
significant ∼10-fold decrease in infectious progeny obtained
fromChlamydia grown in syntaxin 10 siRNA-treated cells (4.93×
106 ± 4.85 × 105) vs. control cells (3.75 × 107 ± 1.62 ×
106). Also apparent in these data is the 1000-fold increase of
progeny produced in control cells between the 24 and 44 h time
points vs. the 200-fold increase in progeny produced in syntaxin
10 knockdown cells within the same time frame. Therefore,
organisms cultivated in the absence of syntaxin 10 demonstrated
a 5-fold lower production rate of infectious progeny. We also
assessed if a longer incubation of Chlamydia in syntaxin 10
siRNA-treated cells would yield more progeny. At 67 h post-
infection, 9.78 × 106 ± 1.12 × 106 IFU/ml were recovered
from syntaxin 10 siRNA-treated cells (Figure 2A). Infectious
progeny are not included for NT siRNA-treated monolayers at
67 h post-infection because of the monolayer being destroyed by
the end of the typical chlamydial developmental cycle; only∼21%
of the monolayer remained intact (quantified by trypan blue
exclusion assay, but also apparent in GAPDH levels, Figure 2B).
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The syntaxin 10 knockdown was 90.35% of control at 67 h
post-infection (∼113 h post-transfection), indicating that the
slight increase (1.98-fold) in infectious progeny was not due
to waning knockdown (Figure 2B). Notably, with an additional
23 h of culture, the organisms grown in syntaxin 10 siRNA-
treated cells never displayed the same rate of growth or output
levels as organisms grown in control cells. Further, syntaxin
10 knockdown monolayers, were largely intact at 67 h post-
infection, in contrast to the control cells. These data support the
notion that loss of syntaxin 10 results in a defect or delay in the
chlamydial developmental cycle.
To further examine the mechanism behind the decrease
in chlamydial infectious progeny recovered from syntaxin 10
siRNA-treated cells, we examined the protein levels of two late
developmental cycle proteins, Hc1 (hctA product) and OmcB by
Western blot analysis (Figure 3). Consistent with the organisms
being in mid-developmental cycle, at 24 h post-infection, there
are no quantifiable differences in Hc1 or OmcB protein levels
between organisms cultivated in NT or syntaxin 10 siRNA-
treated cells. However, at 44 h post-infection, we observed an
increase in protein levels of Hc1 and OmcB in NT siRNA-
treated cells only, although only the difference in Hc1 levels
was statistically significant (Figure 3B). We also tested transcript
levels of the early gene euo by quantitative PCR, as a means to
determine if we were seeing aberrant chlamydial development
where euo transcript is elevated (see e.g., Ouellette et al., 2006).
At 24 h post-infection, euo levels are approaching basal levels
of transcription (Ouellette et al., 2014), and we found transcript
levels increased by only 1.5 fold in organisms grown in syntaxin
10 siRNA-treated cells as compared to organisms grown in
NT siRNA-treated cells (data not shown). While these data are
statically significant, we do not consider these differences to be
biologically significant and they indicate that the chlamydiae
are not in a persistent growth state (see also Figure 4A and
Supplemental Figure 3). We noticed a similar difference when
examining omcB transcripts at 44-h post-infection (data not
shown). Collectively, these data support that the developmental
cycle of chlamydial organisms grown in syntaxin 10 knockdown
cells is delayed or otherwise negatively impacted.
During the later stages of the chlamydial developmental cycle,
the RB either continues to divide or begins to asynchronously
redifferentiate into the infectious EB, forming the intermediate
body (IB); (Ward, 1988). To confirm that loss of syntaxin
10 contributed to a delay in the chlamydial developmental
cycle, we performed transmission electron microscopy (TEM)
at 36 h post-infection in NT and syntaxin 10 siRNA-treated
cells. Immediately apparent was the difference in both the
size of inclusions and types of organisms found in NT siRNA
and syntaxin 10 siRNA-treated cells (representative images,
Figure 4A and Supplemental Figure 3). When we quantified
the different bacterial developmental forms of C. trachomatis
serovar L2 seen in the TEM images, organisms grown in
syntaxin 10 siRNA-treated cells were more likely to be RBs
than infectious EBs compared to organisms cultured in NT
siRNA-treated cells. Similar percentages of IBs were obtained
between experimental groups. Specifically, inclusions grown
in NT siRNA-treated cells contained 45.71 ± 1.31% EBs,
32.80 ± 1/17 IBs, and 21.49 ± 1.29% RBs. Inclusions cultivated
in syntaxin 10 siRNA-treated cells contained 24.53 ± 2.30
EBs, 25.84 ± 2.81 IBs, and 49.63 ± 3.69 RBs (Figure 4B).
Notably, the overall number of organisms per inclusion was
reduced when the bacteria were grown in syntaxin 10 siRNA-
treated cells (65.10 ± 8.141 bacteria/inclusion) as compared
to organisms grown in NT siRNA-treated cells (162.2 ± 10.98
bacteria/inclusion); (Figure 4C). Further, the average diameter of
an inclusion grown in syntaxin 10 knockdown conditions was
10.33µm (±0.6799µm) compared to 14.59µm (±0.4905µm)
in NT siRNA-treated cells (Figure 4D). Overall, these data
indicate that in the absence of syntaxin 10, there is a negative
impact on chlamydial inclusion size and chlamydial growth and
development. Combined, these factors likely contribute to the
decrease and delay in production of infectious progeny.
Lipid Trafficking to Inclusions Grown in Syntaxin
10 Knockdown Cells
We reasoned that defects to chlamydial maturation in the
absence of syntaxin 10might negatively correlate with chlamydial
acquisition of host-derived nutrients. To examine this, we
monitored sphingomyelin trafficking, a well-established marker
of lipid trafficking in chlamydial infected cells, to inclusions
by treating infected siRNA-treated monolayers with C6-NBD-
ceramide and examined inclusions by live cell imaging. We
observed that inclusions growing in syntaxin 10 siRNA-treated
cells (Western blot analysis of knockdown efficiency shown in
Figure 5C) retained substantially higher amounts of fluorescent
lipid than in inclusions grown in NT siRNA-treated cells,
when imaged at equivalent exposures (Figure 5A). To test if
syntaxin 10 knockdown in HeLa cells caused overall retention
of lipid within the Golgi and hence, by default, greater lipid
retention within chlamydial inclusions, we examined uninfected
cells by live cell imaging. After 4 h of back-exchange, there
were no differences in remaining cell-associated fluorescence
between non-targeting (control) and syntaxin 10 siRNA treated
cells (data not shown). Additionally, TLC analysis of mock-
infected HeLa cells treated with either syntaxin 10 or non-
targeting siRNA demonstrated no difference in lipid retention
(cell extracts)/trafficking (back-exchange medium); (data not
shown); therefore, these results indicate that the increase in
NBD-lipid in the chlamydial inclusion was not due to a general
trafficking defect caused by syntaxin 10 knockdown. Further,
we confirmed by TLC that the lipid species incorporated into
purified chlamydial organisms was only NBD-sphingomyelin,
indicating that the increase in fluorescence was not due to an
alternative NBD-lipid product (Supplemental Figure 5).
We had difficulty in quantifying the amount of NBD-
sphingomyelin retained in chlamydial organisms grown
in syntaxin 10 siRNA-treated cells given the diversity of
developmental forms. Therefore, we asked the question whether
inclusions containing mostly RBs (e.g., 18 h post-infection)
labeled with greater intensity than inclusions containing more
EBs (e.g., 26–30 h post-infection). For these studies we infected
HeLa monolayers for 18 or 26 h, labeled the cells for 20min
with C6-NBD-ceramide followed by a 1.5 h back-exchange
period. 18-h inclusions demonstrated a mean of 1331 ± 39.08
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FIGURE 3 | Effect of siRNA knockdown of syntaxin 10 on expression of late chlamydial proteins: Hc1 and OmcB. Syntaxin 10 or non-targeting (NT)
siRNA-treated HeLa cells were infected with C. trachomatis serovar L2 for 24 or 44 h, prior to lysis in Laemmli sample buffer. (A) Equal amounts of protein were loaded
onto SDS-PAGE gels and transferred prior to Western blot analysis using antibodies against chlamydial proteins Hc1, OmcB or chlamydial heat shock protein 60
(cHSP60) or eukaryotic proteins syntaxin 10 and GAPDH. The Western images shown are representative of two independent experiments. (B) Densitometry analysis
was performed on the two independent experiments referred to in (A). These values [expressed in arbitrary units (AU)] were obtained using the Image Studio imaging
software associated with the LI-COR Odyssey Infrared Imaging System and then graphed as mean and standard error of the mean. Statistical analysis included an
ordinary One-Way ANOVA with Tukey’s multiple comparison test in GraphPad Prism 6 software.
(in arbitrary units) brightness per area of inclusion compared
to 26-h inclusions, which demonstrated a mean of 899 ±
31.69 (in arbitrary units) brightness per area of inclusion
(Figure 5B and Supplemental Figure 4). These data indicate
that inclusions filled with mostly RBs are in essence “brighter”
than more mature inclusions. Consistent with these data, 30-h
inclusions grown in NT siRNA-treated cells displayed a mean of
759.6 ± 34.59 integrated density (arbitrary units) per inclusion
area. In comparison, 30-h inclusions grown in syntaxin 10
siRNA-treated cells displayed a mean of 1172 ± 62.19 integrated
density (arbitrary units) per inclusion area. Hence, less mature
inclusions, or inclusions containing more RBs than EBs, are
associated with greater fluorescence per area of the inclusion.
Further, these data are consistent with the notion that loss
of syntaxin 10 negatively impacts chlamydial growth and
development, which correlates with altered nutrient acquisition.
Discussion
In this study, we demonstrate that 3XFLAG-syntaxin 10-positive
structures and/or 3XFLAG-syntaxin 10 alone localizes to the
chlamydial inclusion (Figure 1). To investigate the role of
syntaxin 10 at the inclusion, we depleted syntaxin 10 using
siRNA knockdown. These studies revealed that loss of syntaxin
10 correlates with a significant delay in the progression of
the chlamydial developmental cycle (Figure 2A). Further, loss
of syntaxin 10 was associated with reduced expression of
OmcB and Hc1 (Figure 3), late chlamydial proteins required
for RB to EB differentiation (Hatch et al., 1986; Newhall,
1988; Mygind et al., 1998; Grieshaber et al., 2006). These
results are consistent with TEM analysis demonstrating that
the predominant developmental form at 36 h post-infection in
syntaxin 10 siRNA-treated cells is the RB, compared to the EB
found in control NT siRNA-treated cells (Figure 4). Further, 30-h
inclusions cultivated in syntaxin 10 siRNA-treated cells retained
similar amounts of lipids as more immature inclusions formed at
18 h post-infection in untreated HeLa cells (Figure 5). Given the
heterogeneity of an siRNA knockdown, these results are all the
more striking. Based on these data, we hypothesize that syntaxin
10-positive structures or syntaxin 10 localizes to the chlamydial
inclusion for the purpose of contributing to and/or maintaining
an environment conducive for optimal chlamydial growth and
development by recruiting Golgi-derived vesicles or machinery
to the chlamydial inclusion.
There are five general steps in the chlamydial developmental
cycle: attachment and entry, EB-RB differentiation, RB cell
division, RB-EB differentiation, and release of EBs to infect
neighboring cells (Ward, 1988). Further, genomic profiling of
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FIGURE 4 | Transmission electron micrograph analysis of the effect of syntaxin 10 siRNA knockdown on chlamydial development. Syntaxin 10 (Stx10) or
non-targeting (NT) siRNA-treated HeLa cells were infected with C. trachomatis serovar L2 for 36 h and then processed for transmission electron microscopy as
described in Materials and Methods. For these studies, 40 images each from either Stx10 or NT-siRNA treated cells from 2 independent experiments were examined.
Representative images are shown in (A) and Supplemental Figure 1. These images were used to quantify chlamydial developmental forms (B), total numbers of
organisms per inclusion (C), or inclusion diameter (D). All values were graphed to display the mean and standard error of the mean using GraphPad Prism 6 software.
Statistical analysis included ordinary One-Way ANOVA with Tukey’s multiple comparison test (B) and Student’s t-test (C,D).
expression of chlamydial genes has characterized when specific
genes are expressed during the chlamydial developmental cycle,
suggesting that the expression of certain genes correlates with
optimal chlamydial development (Belland et al., 2003; Nicholson
et al., 2003). In our studies, we found that two late proteins,
associated with RB to EB differentiation, were poorly expressed in
chlamydiae grown in syntaxin 10 siRNA-treated cells (Figure 3).
In conjunction with the TEM data, loss of syntaxin 10 correlated
with a defect or delay in chlamydial development, ultimately
resulting in fewer infectious progeny. Given that syntaxin 10
plays a role in vesicle fusion, we originally hypothesized that
loss of syntaxin 10 would result in mistrafficking or altered
acquisition of a key metabolite, which would negatively impact
chlamydial development. In this context, the loss of syntaxin 10
could lead to two non-mutually exclusive outcomes: erroneous
trafficking of a molecular signal(s), which induces proper
chlamydial growth and development, or loss of direct association
between Golgi structures and the chlamydial inclusion. Our
current studies are unable to distinguish whether syntaxin 10 has
a direct effect (e.g., via interaction with an inclusion membrane
protein) or syntaxin 10 is merely a marker for a subset of vesicles
that provide C. trachomatis with a necessary nutrient. We are
currently examining the syntaxin 10 and Golgi proteins that are
binding partners of syntaxin 10 to characterize their localization
in higher resolution in order to understand their exact roles
in contributing to the optimal chlamydial growth environment.
Ultimately, these studies will help us understand previously
unidentified molecular triggers that impact chlamydial growth
and development.
Given their reduced genome and incomplete metabolic
pathways, RBs must scavenge nutrients and metabolites from the
host in order to replicate. Even though the inclusion membrane
segregates chlamydial organisms from the host cytosol, RBs
interact extensively with the host cell through the inclusion
membrane (Moore and Ouellette, 2014). For example, it is
well established that chlamydiae utilize multiple, redundant
pathways and mechanisms to selectively acquire host cell lipids
(Hackstadt et al., 1996; Beatty, 2006; Heuer et al., 2009; Capmany
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FIGURE 5 | Effect of syntaxin 10 siRNA knockdown on
NBD-sphingomyelin trafficking to the chlamydial inclusion. (A) Syntaxin
10 (Stx10) or non-targeting (NT) siRNA-treated HeLa cells were infected with
C. trachomatis serovar L2 for 24 h, labeled with NBD-ceramide, and treated
with back-exchange medium for an additional 3 h. Samples were imaged at
40X magnification with a 200ms exposure time using an Axiovert 200M
Imager with the AxioCam HRm camera (Carl Zeiss Microscopy, LLC). These
images are representative of 3 independent experiments. (B) Untreated HeLa
cells were infected with C. trachomatis serovar L2 for 18 or 26 h, labeled with
NBD-ceramide and back-exchanged for 1.5 h. In addition, Stx10 or NT
siRNA-treated HeLa cells were infected with C. trachomatis serovar L2 for
30 h, labeled and back-exchanged as 18- and 26-h samples. Samples from
two independent experiments were imaged using 60X magnification Olympus
BX 60 fluorescent scope and images taken with a Nikon DS-Qi1Mc camera,
with a 40ms exposure for 18- 26- and NT siRNA treated samples, and a 20ms
exposure time for syntaxin 10-treated samples, as described in Materials and
Methods. Individual data points, including the mean and standard error of the
mean, were graphed using GraphPad Prism 6 software. Statistical analysis
included an ordinary One-Way ANOVA with a Tukey’s multiple comparison
test. Representative images used in the quantitation are provided in
Supplemental Figure 4. (C) A representative Western blot to demonstrate
efficient knockdown of Stx10 compared to the loading control GAPDH.
and Damiani, 2010; Derré et al., 2011; Elwell et al., 2011;
Cox et al., 2012; Kabeiseman et al., 2013; Boncompain et al.,
2014). It is likely that the organisms are also simultaneously
acquiring other metabolites, including the “molecular trigger”
that prompts RB to EB differentiation, when acquiring host-
derived lipids. Potentially impacting chlamydial growth and
development is the smaller sizes of the chlamydial inclusions
formed in syntaxin 10 siRNA-treated cells (Figure 4D). Based on
the data demonstrating loss of syntaxin 10 resulted in decreased
infectious progeny and smaller inclusions, we anticipated that
loss of syntaxin 10 would negatively affect chlamydial acquisition
of host lipids, including host-derived sphingomyelin. This
hypothesis is consistent with previous data from the laboratory
demonstrating that knockdown of VAMP4, a trans-Golgi SNARE
that traffics to the inclusion, results in fewer infectious progeny
and a disruption of lipid trafficking to the chlamydial inclusion
(Kabeiseman et al., 2013). However, live cell imaging results
contradicted this hypothesis (Figure 5). Using NBD-ceramide as
a proxy to study Golgi-derived lipid trafficking to the chlamydial
inclusion, we found that knockdown of syntaxin 10 resulted in
“brighter” inclusions than what was observed in control siRNA-
treated cells at the same time point. Interestingly, 30-h chlamydial
inclusions grown in syntaxin 10 siRNA-treated cells retain similar
amounts of lipid as 18-h inclusions grown in untreatedHeLa cells
(Figure 5B). Combined, these data suggest that sphingomyelin
trafficking to the inclusion is not hindered by the loss of syntaxin
10, and, further, the presence of more RBs correlates with
“greater” retention of fluorescent lipid. These results primarily
support the conclusion that increased lipid retention is consistent
with the abundance of immature developmental forms associated
with growth in syntaxin 10 knockdown cells and not due to
a trafficking defect of sphingomyelin caused by the absence of
syntaxin 10.
There are two events that likely occur during ceramide-
derived sphingomyelin labeling of chlamydiae: trafficking to
the inclusion from the ER (and subsequently through the
Golgi) and retention by the organism (Hackstadt et al., 1995,
1996; Scidmore et al., 1996). Prior work from Scidmore
et al. (Scidmore et al., 1996) demonstrated that sphingomyelin
trafficking to the inclusion was blocked in the presence of
chloramphenicol when the antibiotic was added at 2–4 h post-
infection, demonstrating a role for chlamydial protein synthesis
in this process. The factors involved in retention of lipid are not
clearly defined. Our Stx10 knockdown data indicate that Stx10
does not function in sphingomyelin trafficking to or retention by
chlamydiae within the inclusion and suggests that sphingomyelin
is trafficked through a specific subset of vesicles not characterized
by this marker (syntaxin 10). Another previous study linked
sphingomyelin acquisition to the progression of chlamydiae
through the developmental cycle (Robertson et al., 2009). Our
data suggest that there are additional metabolites that are
necessary for chlamydiae to progress through the developmental
cycle. This is consistent with other data demonstrating that the
inclusion interacts with specific subsets of exocytic vesicles and
will aid in our understanding of what nutrients and markers are
delivered to the inclusion and by what route.
What is not ruled out by these studies is the possibility
that the abundance of immature chlamydiae, due to the loss of
syntaxin 10, would create a perpetual imbalance of chlamydial
lipid acquisition to further stall the progress of chlamydial
development. Previous studies have demonstrated that an over-
accumulation of a nutrient at the chlamydial inclusion resulted
in negative effects on chlamydial development (Ouellette and
Carabeo, 2010). Hence, an imbalance in the amount of lipid
in inclusions grown in syntaxin 10 siRNA-treated cells may
contribute to defects in the differentiation of RBs to EBs in the
later stages of chlamydial development, ultimately contributing
to lower yields of EBs (Figure 2A). RBs have a fragile cell
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 9 September 2015 | Volume 5 | Article 68
Lucas et al. Syntaxin 10 required for chlamydial development
wall, where an overabundance of a specific lipid may alter
their membrane fluidity. Accumulation of sphingomyelin in
chlamydial cell membranes will likely stiffen the bacterial
membranes since sphingomyelin contains hydrophobic chains,
which tend to be much more saturated than other phospholipids
(Barenholz and Thompson, 1980; Van Blitterswijk et al., 1981;
Chiu et al., 2003). Excessive sphingomyelin may prevent the
chlamydial cell membrane from being repackaged properly,
which would potentially lead to defects in differentiation at
late stages of chlamydial development, inefficient division, or
a reduction in growth rate. Unfortunately, our data do not
distinguish between “cause” and “effect.” Specifically, we cannot
definitively conclude that the lack of progression through
the developmental cycle of Chlamydia grown in syntaxin
10 siRNA-treated cells is due to excess lipid accumulating
within the inclusion as opposed to the distinct conclusion
that immature developmental forms naturally retain “more”
lipid given their greater membrane surface area compared to
mature EBs.
Concluding Remarks
For the first time, we demonstrate that trans-Golgi SNARE
protein syntaxin 10-positive structures and/or syntaxin 10
localizes to the chlamydial inclusion. Further, syntaxin 10 is
utilized at the chlamydial inclusion to support optimal growth
and development, as loss of syntaxin 10 results in significant
delays in production of chlamydial progeny.
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